Cargando…
COX-2 upregulation by tumour cells post-chemotherapy fuels the immune evasive dark side of cancer inflammation
Cytotoxic therapies, such as chemotherapy and radiotherapy, are mainstays of cancer treatment for both early and unresectable, advanced disease. In addition to debulking the tumour mass through direct killing of proliferating tumour cells, these treatments can promote tumour control via immune-stimu...
Autores principales: | Bell, Charlotte R., Zelenay, Santiago |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shared Science Publishers OG
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9442149/ https://www.ncbi.nlm.nih.gov/pubmed/36120509 http://dx.doi.org/10.15698/cst2022.09.271 |
Ejemplares similares
-
Host upregulation of lipid droplets drives antiviral responses
por: Monson, Ebony A., et al.
Publicado: (2021) -
Tissue-resident memory T cells orchestrate tumour-immune equilibrium
por: Park, Simone L., et al.
Publicado: (2019) -
GFI1’s role in DNA repair suggests implications for tumour cell response to treatment
por: Vadnais, Charles, et al.
Publicado: (2018) -
Post‐transcriptional gene regulation in the biology and virulence of Candida albicans
por: Verma‐Gaur, Jiyoti, et al.
Publicado: (2016) -
A new way to regulate inflammation: selective autophagic degradation of IKKγ mediated by ANGPTL8
por: Zhang, Yu, et al.
Publicado: (2018)